It’s been exactly one year since cryoDuck B.V. was founded. Reflecting on the past year, I am filled...
This April's Clovertex Target of the Month is the Androgen Receptor (AR), a critical protein involve...
This March's Clovertex Target of the Month is CXCR4 following a Regeneron preprint that presents tet...
This February, we're excited to shine our Clovertex Target of the Month spotlight on the estrogen re...
This January 2024, we're spotlighting Bruton's tyrosine kinase (BTK) as our Clovertex Target of the ...
Medicine experienced a monumental moment in 2023 with the recognition of BCL11A as the 2023 Cloverte...
Amidst a flurry of big pharma deals, the Muscarinic acetylcholine receptor subtype M4 has emerged as...
I was recently a panelist at the 31st Protein Structure Determination in Industry Meeting (PSDI 2023...
This November, we highlight the folate receptor alpha (FRα) as the 'Clovertex Target of the Month'. ...
For October 2023, we have the Human Epidermal growth factor Receptor 3 (HER3) as the 'Clovertex Drug...